The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress

By Scribner A.W.   Loscalzo J.   Napoli C.  

European Journal of Pharmacology, Vol. 482, Iss. 1, 2003-12 ,pp. : 95-99

Elsevier

Access to resources Recommend Favorite

Chemical Composition of and Inhibition of Angiotensin-Converting Enzyme by Senecio samnitum huet

By Tundis R.   Loizzo M.R.   Statti G.A.   Deguin B.   Amissah R.   Houghton P.J.   Menichini F.  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 43, Iss. 7, 2005-10 ,pp. : 605-608

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibition Influences Serum Levels of Advanced Glycation End Products in Patients with Coronary Artery Disease: Results from a HOPE Substudy

By  

Heart Drug, Vol. 3, Iss. 2, 2003-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control: Editorial to: “Secondary Prevention of Coronary Disease with ACE Inhibition—Does Blood Pressure Reduction with Perindopril Explain the Benefits in EUROPA?” by Remme et al.

By Verma Anil   Ventura Hector  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 109-111

Springer Publishing Company

Access to resources Recommend Favorite